VARIABLES PREDICTING DEEP FUNGAL-INFECTIONS IN BONE-MARROW TRANSPLANT RECIPIENTS
- 1 November 1989
- journal article
- research article
- Vol. 4 (6) , 635-641
Abstract
Deep fungal infections (FI) were diagnosed in 27 out of 209 consecutive bone marrow transplantation (BMT) recipients. Autopsy verified that the incidence of deep FI was 10% and the overall incidence was 13%. Using bivariate logistic regression analysis at the time of BMT, high recipient age (p = 0.003), low bone marrow cell dose (p = 0.007), recipient cytomegalovirus (CMV) seropositivity (p = 0.009) and splenectomy (p = 0.03) were significant risk factors for deep FI. In multivariate analysis, splenectomy (p = 0.008), recipient CMV seropositivity (p = 0.01) and low bone marrow cell dose (p = 0.01) held as significant. At 30 days post-BMT anti-thymocyte globulin treatment (p = 0.0006) and graft-versus-host disease grade II-IV (p = 0.005) were significant risk variables in bivariate logistic regression analysis and Fisher''s exact probability test. Patients with these risk factors are candidates for treatment with antifungal drugs when they suffer from leukopenia and unclear fever.This publication has 14 references indexed in Scilit:
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- DEATH BY GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMYTransplantation, 1985
- Diagnosis of systemic candidiasis by latex agglutination for serum antigenJournal of Clinical Microbiology, 1985
- FASTER IMMUNOLOGICAL RECOVERY AFTER BONE MARROW TRANSPLANTATION IN PATIENTS WITHOUT CYTOMEGALOVIRUS INFECTIONTransplantation, 1985
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortalityJAMA, 1983
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Serologic Immunodiagnosis of Invasive AspergillosisThe Journal of Infectious Diseases, 1980
- GRANULOCYTE FUNCTION IN HUMAN ALLOGENEIC MARROW GRAFT RECIPIENTS1980
- The role of antibiotics in the pathogenesis of Candida infectionsThe American Journal of Medicine, 1966